H.C. Wainwright Reiterates Buy Rating on AEON Biopharma, Inc (AEON)
Tweet Send to a Friend
H.C. Wainwright analyst Douglas Tsao reiterated a Buy rating and $5.00 price target on AEON Biopharma, Inc (NYSE: AEON).The analyst ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
